BioCentury
ARTICLE | Company News

General Electric sales and marketing update

April 15, 2013 7:00 AM UTC

General Electric's Clarient Diagnostic Services Inc. company launched its next-generation sequencing assay for use in clinical trials for solid tumors. Clarient will perform the assay, which targets 2...